|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 253.69 USD | -2.55% |
|
-7.96% | +2.90% |
| 04/03 | Krystal Biotech Insider Sold Shares Worth $3,252,824, According to a Recent SEC Filing | MT |
| 24/02 | Krystal Biotech Insider Sold Shares Worth $4,953,694, According to a Recent SEC Filing | MT |
| Capitalization | 741.59Cr 639.4Cr 577.2Cr 553.83Cr 1.01TCr 68TCr 1.06TCr 6.82TCr 2.73TCr 33TCr 2.78TCr 2.72TCr 1,16900Cr | P/E ratio 2026 * |
32.1x | P/E ratio 2027 * | 23x |
|---|---|---|---|---|---|
| Enterprise value | 741.59Cr 639.4Cr 577.2Cr 553.83Cr 1.01TCr 68TCr 1.06TCr 6.82TCr 2.73TCr 33TCr 2.78TCr 2.72TCr 1,16900Cr | EV / Sales 2026 * |
13.7x | EV / Sales 2027 * | 10.6x |
| Free-Float |
87.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Krystal Biotech, Inc.
| 1 day | -2.55% | ||
| 1 week | -7.96% | ||
| Current month | -7.96% | ||
| 1 month | -6.98% | ||
| 3 months | +8.35% | ||
| 6 months | +68.82% | ||
| Current year | +2.90% |
| 1 week | 251.18 |  | 270 |
| 1 month | 251.18 | | 298.3 |
| Current year | 235.6 | | 298.3 |
| 1 year | 122.8 | | 298.3 |
| 3 years | 70.51 | | 298.3 |
| 5 years | 38.86 | | 298.3 |
| 10 years | 8.03 | | 298.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Suma M. Krishnan
COO | Chief Operating Officer | 61 | 15/04/2016 |
| Chief Executive Officer | 61 | 15/04/2016 | |
Trevor Parry
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 61 | 15/04/2016 | |
Suma M. Krishnan
BRD | Director/Board Member | 61 | 15/04/2016 |
Daniel Janney
BRD | Director/Board Member | 60 | 01/11/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.55% | -7.96% | +40.99% | +225.33% | 741.59Cr | |
| -0.66% | -2.79% | +7.40% | -1.81% | 7.8TCr | |
| -2.68% | -0.52% | +33.16% | +214.46% | 5.54TCr | |
| -0.18% | +64.40% | +64.40% | +64.40% | 5.12TCr | |
| -0.15% | -0.33% | -43.67% | -50.73% | 4.94TCr | |
| -1.71% | -3.62% | +22.94% | -30.21% | 2.71TCr | |
| -2.43% | -1.96% | +47.49% | -62.76% | 2.07TCr | |
| -1.43% | -5.26% | +35.53% | +28.99% | 1.91TCr | |
| +6.18% | -2.12% | +107.21% | +97.16% | 1.85TCr | |
| -1.21% | -4.75% | +27.92% | +56.07% | 1.41TCr | |
| Average | -0.68% | -3.68% | +34.34% | +54.09% | 3.41TCr | |
| Weighted average by Cap. | -0.77% | -3.09% | +25.00% | +44.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 54Cr 47Cr 42Cr 40Cr 74Cr 4.98TCr 77Cr 498.15Cr 199.57Cr 2.39TCr 203.2Cr 198.86Cr 8.53TCr | 70Cr 60Cr 54Cr 52Cr 95Cr 6.43TCr 100Cr 643.64Cr 257.85Cr 3.08TCr 262.54Cr 256.95Cr 11TCr |
| Net income | 24Cr 21Cr 19Cr 18Cr 33Cr 2.2TCr 34Cr 220.53Cr 88Cr 1.06TCr 90Cr 88Cr 3.78TCr | 36Cr 31Cr 28Cr 27Cr 49Cr 3.32TCr 52Cr 332.89Cr 133.36Cr 1.59TCr 135.79Cr 132.89Cr 5.7TCr |
| Net Debt | - | - |
Employees
295
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | 253.69 $ | -2.55% | 2,44,409 |
| 05/26/05 | 260.33 $ | -1.76% | 2,76,513 |
| 04/26/04 | 265.00 $ | +0.45% | 2,34,840 |
| 03/26/03 | 263.80 $ | +1.93% | 2,23,273 |
| 02/26/02 | 258.81 $ | -6.11% | 3,18,104 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
253.69USD
Average target price
313.22USD
Spread / Average Target
+23.47%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- KRYS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition